Financial Statements · Financial Reporting

Takeda Pharma OÜ

Official identifier 10323690Record date 31 Mar 2022
Estonia

Report

Legal form
OÜ
Report status
Registered

Dates

Reporting year
2021
Period start
1 Apr 2021
Submitted date
7 Oct 2022

Report

Consolidated
No
Audited
Yes

Financial metrics

StatementMetricValue
Balance sheetAssets4,259,000
Balance sheetCash and cash equivalents61,000
Balance sheetCurrent assets3,932,000
Balance sheetCurrent liabilities2,236,000
Balance sheetEquity1,880,000
Balance sheetShare capital at nominal value141,000
Balance sheetNon-current assets327,000
Balance sheetNon-current liabilities143,000
Balance sheetRetained earnings (loss) from previous periods1,881,000
Kahjumi katmise ettepanekRetained earnings (loss) from previous periods1,881,000
Income statement scheme 1Depreciation and impairment of non-current assets0
Income statement scheme 1Labour costs0
Income statement scheme 1Revenue2,992,000
Income statement scheme 1Annual period profit / loss-1,492,000
Income statement scheme 1Operating profit (loss)104,000
Income statement scheme 1Profit (loss) before income tax104,000
Note: Labour costsEmployees11
Note: Labour costsLabour costs-823,000
Rahavoogude aruanne kaudsel meetodilOperating profit (loss)104,000

Linked company

Company: Takeda Pharma OÜ

Source

Estonian e-Business Register Annual Reports open data

View published source

Back to Financial Statements